Study: SSRI, NSAID combo increases GI bleeding

10/10/2007 | United Press International

The combined use of selective serotonin reuptake inhibitors and nonsteroidal anti-inflammatory drugs to treat depression and other illnesses may heighten the risk of gastrointestinal bleeding by more than 600%, researchers warned. Data from four studies involving 153,000 patients showed that GI bleeding occurred after an average of 25 weeks in patients who took SSRIs, 67% of whom were also taking NSAIDs.

View Full Article in:

United Press International

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI